Vetnews | April 2024 40 « BACK TO CONTENTS Feline Chronic Gingivostomatitis (FCGS) is a challenging and often perplexing condition that can be difficult to manage. It can affect up to 26% of the cat population (Soltero-Rivera et al., 2023). Cats of any breed and any age can be affected, although the mean age for cats presenting with this condition is around 7 years of age and domestic short-hair cats tend to overpresent (Dolieslager, 2013, Druet and Hennet, 2017). It’s characterized by persistent inflammation of the gingiva and the area lateral of the palatoglossal folds, causing significant discomfort and pain for affected cats. The pharynx, oesophagus, tongue and lips can also be affected (Dolieslager et al., 2013, Soltero-Rivera et al., 2023). It is crucial to understand the disease process to manage these patients effectively and to try to improve their quality of life. Cats with this condition often present with symptoms such as salivation, halitosis, difficulty eating or preference for soft food, reluctance to groom themself, weight loss, and sometimes reduced socialization due to the chronic discomfort they experience (Jennings et al., 2015). The disease can manifest clinically in two different ways – either ulceration or proliferation of the oral tissues, and some patients can have a combination of the two (Vapniarsky et al., 2020, Soltero-Rivera et al., 2023). It is thought that FCGS is an immune-mediated condition which has local as well as systemic effects (Soltero-Rivera et al., 2023). The exact cause as to what may trigger the immune response to have this exaggerated response remains unclear. Several viruses and bacteria, as well as environmental factors such as multicat households, have been implicated in this disease. Feline leukaemia virus (FeLV), feline immunodeficiency virus (FIV), feline herpes virus (FHV) and feline calicivirus (FCV) specifically, have been found to play a role in this disease. In a study by Knowles et al. (1991), healthy cats were inoculated with FCV where the cats developed acute oral ulceration but failed to cause chronic stomatitis in these cases in the 10-month period of the study. Although FCV may not be solely responsible for causing disease, current literature at least supports the role of FCV in modulating the severity of FCGS (Soltero-Rivera et al., 2023). FCGS can be diagnosed with a thorough oral examination which can be done in the consult room or for more painful patients, under sedation. When opening the mouth of a cat with FCGS, bilateral inflammation of the area lateral of the palatoglossal folds will be noticed which is pathognomonic for this disease (Winer et al., 2016) (previously, incorrectly, called faucitis). The glossopalatine mucosa is the preferred area to take a biopsy from for histopathology for confirmation of disease, as this area is unlikely to be affected by periodontal disease or tooth resorption (Harley et al., 2011). Patients presenting with unilateral or very focal inflammation need to be assessed for other conditions such as squamous cell carcinoma. Treatment modalities for FCGS encompass both medical and surgical approaches. Surgical treatment seems to be superior to medical treatment in the long term (Lee et al., 2020) as patients usually become refractory to medical treatment (Harley, 2000). The treatment of choice is either a Partial Mouth Extraction (PME) or Full Mouth dental Extraction (FME), and should a patient not respond to treatment after a PME, an FME should be performed. When a patient presents with only caudal oral inflammation, a PME (all the pre-molar and molar teeth) can be performed, but if a patient has diffuse oral inflammation, an FME is the only option (Soltero-Rivera et al., 2023). In the dental clinic at the Onderstepoort Veterinary Academic Hospital (OVAH) we more often do an FME as owners are hesitant to opt for another procedure should their cat not respond to PME. As mentioned, not all patients respond to surgical treatment, and it is these cases that require intensive lifelong management. According to a study by Jennings et al. (2015) on the response of cats after either a PME or FME, it was found that 28.4% of cats had complete resolution, 39% marked clinical improvement, 26.3% had only mild improvement and 6.3% had no improvement. Treatment options for patients refractory to surgical treatment entail either immunosuppressive treatment (corticosteroids or ciclosporin), feline recombinant interferon omega (IFN Ω) or mesenchymal stem cell therapy (Soltero-Rivera et al., 2023). To the author’s knowledge, IFN Ω and mesenchymal stem cell therapy is not yet available in South Africa. Appropriate analgesia to manage discomfort and pain in these patients is important. Drugs such as amantadine, gabapentin, buprenorphine and NSAID’s can be used (Soltero-Rivera et al., 2023). Each case should be evaluated individually for severity of disease, ease of administration of medication and owner compliance, and a specific treatment plan should be developed. The response to treatment needs to be monitored with regular follow-ups to determine if the patient is managed adequately. Some patients will end up being euthanised as the response to treatment is unsatisfactory, and owners feel that they are not able to manage the cat well enough at home or due to financial constraints. At the dental clinic in Onderstepoort Veterinary Academic Hospital, there is a study currently on patients with FCGS to evaluate serum amyloid A, albumin and iron (acute phase reactants) as well as Dental Column Feline Chronic Gingivostomatitis: Clinical overview and therapeutic strategies Dr. Mareli van de Wetering, Prof. Gerhard Steenkamp
RkJQdWJsaXNoZXIy OTc5MDU=